{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T09:08:10Z","timestamp":1774602490466,"version":"3.50.1"},"reference-count":89,"publisher":"Elsevier","isbn-type":[{"value":"9780443414237","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015548","name":"\u0110\u1ea1i h\u1ecdc Qu\u1ed1c gia H\u00e0 N\u1ed9i","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015548","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.ircmb.2025.10.002","type":"book-chapter","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:58:18Z","timestamp":1761364698000},"page":"135-155","source":"Crossref","is-referenced-by-count":0,"title":["The current findings and potential applications of breast cancer epigenetics"],"prefix":"10.1016","author":[{"given":"Yen-Vy","family":"Nguyen Thi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quy","family":"Do Van","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai Linh Duong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanh","family":"Van Cao Thi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinh-Toi","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/bs.ircmb.2025.10.002_bib1","doi-asserted-by":"crossref","DOI":"10.36877\/pmmb.a0000099","article-title":"Molecular profiling and detection methods of microRNA in cancer research","volume":"3","author":"Ab Mutalib","year":"2020","journal-title":"Progress In Microbes & Molecular Biology"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120047","article-title":"The molecular mechanisms and therapeutic potential of EZH2 in breast cancer","volume":"286","author":"Adibfar","year":"2021","journal-title":"Life Sciences"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib3","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/modpathol.3800822","article-title":"DNA methylation in breast and colorectal cancers","volume":"20","author":"Agrawal","year":"2007","journal-title":"Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology, Inc"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib4","unstructured":"N.M. Al Aboud C. Tupper I. Jialal Genetics, epigenetic mechanism. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532999\/."},{"key":"10.1016\/bs.ircmb.2025.10.002_bib5","first-page":"895","article-title":"Histone modifications in cancer","author":"Audia","year":"2015","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib6","doi-asserted-by":"crossref","unstructured":"Baylin, S.B.,\u00a0&\u00a0Jones,\u00a0P.A.\u00a0Epigenetic Determinants of Cancer. LID - https:\/\/doi.org\/10.1101\/cshperspect.a019505 [doi] LID - a019505. (1943-0264 (Electronic)).","DOI":"10.1101\/cshperspect.a019505"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib7","doi-asserted-by":"crossref","DOI":"10.1046\/j.1440-1622.1999.01515.x","article-title":"The genetic basis of breast cancer and its clinical implications","author":"Bennett","year":"1999","journal-title":"The Australian and New Zealand Journal of Surgery"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctarc.2019.100125","article-title":"Diagnostic utility of epigenetics in breast cancer\u2013a review","volume":"19","author":"Bhat","year":"2019","journal-title":"Cancer Treatment and Research Communications"},{"issue":"21","key":"10.1016\/bs.ircmb.2025.10.002_bib9","doi-asserted-by":"crossref","first-page":"10308","DOI":"10.1158\/0008-5472.CAN-06-1052","article-title":"A repressive epigenetic domino effect confers susceptibility to breast epithelial cell transformation: Implications for predicting breast cancer risk","volume":"66","author":"Bistulfi","year":"2006","journal-title":"Cancer Research"},{"issue":"1","key":"10.1016\/bs.ircmb.2025.10.002_bib10","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1038\/s41467-020-17227-z","article-title":"Multi-faceted epigenetic dysregulation of gene expression promotes esophageal squamous cell carcinoma","volume":"11","author":"Cao","year":"2020","journal-title":"Nature Communications"},{"issue":"9","key":"10.1016\/bs.ircmb.2025.10.002_bib11","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7150\/jca.12174","article-title":"Promoter hypermethylation in White blood cell DNA and breast cancer risk","volume":"6","author":"Cho","year":"2015","journal-title":"Journal of Cancer"},{"issue":"17","key":"10.1016\/bs.ircmb.2025.10.002_bib12","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1200\/JCO.18.01265","article-title":"Efficacy and safety of pembrolizumab in previously treated advanced cervical cancer: Results from the phase II KEYNOTE-158 study","volume":"37","author":"Chung","year":"2019","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib13","unstructured":"Corso, G.A.-O., et al.\u00a0(no date).\u00a0E-cadherin deregulation in breast cancer. (1582\u20134934 (Electronic))."},{"key":"10.1016\/bs.ircmb.2025.10.002_bib14","doi-asserted-by":"crossref","first-page":"1116805","DOI":"10.3389\/fcell.2023.1116805","article-title":"Epigenetic reprogramming in cancer: From diagnosis to treatment","volume":"11","author":"Costa","year":"2023","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"1","key":"10.1016\/bs.ircmb.2025.10.002_bib15","first-page":"104","article-title":"Breast cancer: Updated and deep insights","volume":"6","author":"Cuthrell","year":"2023","journal-title":"International Research Journal of Oncology"},{"issue":"1","key":"10.1016\/bs.ircmb.2025.10.002_bib16","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1186\/s12885-020-07543-4","article-title":"Epigenome-wide DNA methylation and risk of breast cancer: A systematic review","volume":"20","author":"Ennour-Idrissi","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib17","unstructured":"Feinberg, A.P., Koldobskiy, M.A., &\u00a0G\u00f6nd\u00f6r, A.\u00a0(no date). Epigenetic modulators, modifiers and mediators in cancer aetiology and progression. (1471\u20130064 (Electronic))."},{"issue":"1","key":"10.1016\/bs.ircmb.2025.10.002_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrg1748","article-title":"The epigenetic progenitor origin of human cancer","volume":"7","author":"Feinberg","year":"2006","journal-title":"Nature Reviews. Genetics"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib19","unstructured":"Feinberg, A.P., Ohlsson, R., &\u00a0Henikoff, S.\u00a0(no date). The epigenetic progenitor origin of human cancer. (1471\u20130056 (Print))."},{"key":"10.1016\/bs.ircmb.2025.10.002_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.946811","article-title":"Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond","volume":"13","author":"Feng","year":"2022","journal-title":"Frontiers in Pharmacology"},{"issue":"6","key":"10.1016\/bs.ircmb.2025.10.002_bib21","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"European Journal of Cancer"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib22","unstructured":"Guo, P., et al.\u00a0(no date). The histone acetylation modifications of breast cancer and their therapeutic implications. (1532\u20132807 (Electronic))."},{"issue":"4","key":"10.1016\/bs.ircmb.2025.10.002_bib23","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s12253-018-0433-5","article-title":"The histone acetylation modifications of breast cancer and their therapeutic implications","volume":"24","author":"Guo","year":"2018","journal-title":"Pathology & Oncology Research"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.700947","article-title":"Characterization of histone deacetylase mechanisms in cancer development","volume":"11","author":"Hai","year":"2021","journal-title":"Frontiers in oncology"},{"issue":"10","key":"10.1016\/bs.ircmb.2025.10.002_bib25","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1101\/gr.268292.120","article-title":"Pan-cancer multi-omics analysis and orthogonal experimental assessment of epigenetic driver genes","volume":"30","author":"Halaburkova","year":"2020","journal-title":"Genome Research"},{"issue":"9","key":"10.1016\/bs.ircmb.2025.10.002_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.879","article-title":"The role of BRCA1\/2 in hereditary and familial breast and ovarian cancers","volume":"7","author":"Hawsawi","year":"2019","journal-title":"Molecular Genetics & Genomic Medicine"},{"issue":"2","key":"10.1016\/bs.ircmb.2025.10.002_bib27","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1101\/gr.125872.111","article-title":"Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer","volume":"22","author":"Hon","year":"2012","journal-title":"Genome Research"},{"issue":"6","key":"10.1016\/bs.ircmb.2025.10.002_bib28","doi-asserted-by":"crossref","first-page":"582","DOI":"10.21873\/cgp.20407","article-title":"SUV39H1 expression as a guideline for omitting radiotherapy in lymph node-positive triple-negative breast cancer patients","volume":"20","author":"Huang","year":"2023","journal-title":"Cancer Genomics & Proteomics"},{"issue":"6","key":"10.1016\/bs.ircmb.2025.10.002_bib29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/bcr2925","article-title":"Epigenetics in breast cancer: What's new?","volume":"13","author":"Huang","year":"2011","journal-title":"Breast Cancer Research"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib30","series-title":"Epigenetics protocols","first-page":"297","article-title":"Inhibition of histone deacetylases","author":"Huang","year":"2011"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib31","doi-asserted-by":"crossref","unstructured":"Jeusset, L.M.,\u00a0&\u00a0McManus, K.A.-O.\u00a0(no date).\u00a0Developing targeted therapies that exploit aberrant histone ubiquitination in cancer. LID - https:\/\/doi.org\/10.3390\/cells8020165 [doi] LID - 165. (2073\u20134409 (Print)).","DOI":"10.3390\/cells8020165"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib32","series-title":"StatPearls [Internet]","article-title":"Genetics, epigenetic mechanism","author":"Jialal","year":"2025"},{"issue":"3","key":"10.1016\/bs.ircmb.2025.10.002_bib33","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/cvr\/cvr097","article-title":"Non-coding RNAs as regulators of gene expression and epigenetics","volume":"90","author":"Kaikkonen","year":"2011","journal-title":"Cardiovascular Research"},{"issue":"6","key":"10.1016\/bs.ircmb.2025.10.002_bib34","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/07853890.2014.923740","article-title":"Epigenetic reprogramming in breast cancer: From new targets to new therapies","volume":"46","author":"Katz","year":"2014","journal-title":"Annals of Medicine"},{"issue":"7","key":"10.1016\/bs.ircmb.2025.10.002_bib35","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1200\/JCO.2012.45.9859","article-title":"Breast cancer follow-up and management after primary treatment: American society of clinical oncology clinical practice guideline update","volume":"31","author":"Khatcheressian","year":"2013","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib36","doi-asserted-by":"crossref","unstructured":"Kim, A., et al.\u00a0(no date).\u00a0Epigenetic regulation in breast cancer: Insights on Epidrugs. LID - https:\/\/doi.org\/10.3390\/epigenomes7010006 [doi] LID - 6. (2075\u20134655 (Electronic)).","DOI":"10.3390\/epigenomes7010006"},{"issue":"3","key":"10.1016\/bs.ircmb.2025.10.002_bib37","doi-asserted-by":"crossref","first-page":"zcab036","DOI":"10.1093\/narcan\/zcab036","article-title":"Regulatory roles of RNA modifications in breast cancer","volume":"3","author":"Kumari","year":"2021","journal-title":"NAR Cancer"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib38","series-title":"Seminars in cancer biology","article-title":"Cancer epigenetics: Past, present and future","author":"Lee","year":"2022"},{"issue":"1","key":"10.1016\/bs.ircmb.2025.10.002_bib39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/PAI.0000000000000261","article-title":"Association between phosphorylated histone H3 and oncotype DX recurrence scores in breast cancer","volume":"25","author":"Lee","year":"2017","journal-title":"Applied Immunohistochemistry & Molecular Morphology"},{"issue":"15","key":"10.1016\/bs.ircmb.2025.10.002_bib40","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.3390\/cancers15154005","article-title":"Emerging role of epigenetic modifiers in breast cancer pathogenesis and therapeutic response","volume":"15","author":"Lee","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/bs.ircmb.2025.10.002_bib41","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13045-019-0828-0","article-title":"Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: Results from the global burden of disease study 2017","volume":"12","author":"Li","year":"2019","journal-title":"Journal of Hematology & Oncology"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib42","article-title":"Targeting histone modifications in breast cancer: A precise weapon on the way","volume":"9","author":"Li","year":"2021","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"7","key":"10.1016\/bs.ircmb.2025.10.002_bib43","first-page":"94","article-title":"Roles of lncRNA in breast cancer","author":"Liu","year":"2015","journal-title":"Frontiers in Bioscience (Scholar edition)"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib44","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3390\/curroncol28010091","article-title":"A histone acetylation modulator gene signature for classification and prognosis of breast cancer","volume":"28","author":"Long","year":"2021","journal-title":"Current Oncology"},{"issue":"9","key":"10.1016\/bs.ircmb.2025.10.002_bib45","doi-asserted-by":"crossref","first-page":"jcs236125","DOI":"10.1242\/jcs.236125","article-title":"5-Aza-2\u2032-deoxycytidine advances the epithelial\u2013mesenchymal transition of breast cancer cells by demethylating Sipa1 promoter-proximal elements","volume":"133","author":"Lu","year":"2020","journal-title":"Journal of Cell Science"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215929","article-title":"Non-coding RNAs in breast cancer: Implications for programmed cell death","volume":"550","author":"Luo","year":"2022","journal-title":"Cancer Letters"},{"issue":"1","key":"10.1016\/bs.ircmb.2025.10.002_bib47","doi-asserted-by":"crossref","DOI":"10.36877\/pmmb.a0000083","article-title":"Insight of microRNA role in colorectal cancer","volume":"3","author":"Lye","year":"2020","journal-title":"Progress in Microbes & Molecular Biology"},{"issue":"11","key":"10.1016\/bs.ircmb.2025.10.002_bib48","doi-asserted-by":"crossref","first-page":"9360","DOI":"10.3390\/ijms24119360","article-title":"The mechanism of DNA methylation and miRNA in breast cancer","volume":"24","author":"Ma","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib49","first-page":"2023","article-title":"Mitochondrial DNA methylation is a predictor of immunotherapy response and prognosis in breast cancer: scRNA-seq and bulk-seq data insights","volume":"14","author":"Ma","year":"2023","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/bs.ircmb.2025.10.002_bib50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"Moore","year":"2013","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/bs.ircmb.2025.10.002_bib51","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/1471-2407-13-215","article-title":"Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer-overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression","volume":"13","author":"M\u00fcller","year":"2013","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/bs.ircmb.2025.10.002_bib52","doi-asserted-by":"crossref","DOI":"10.36877\/pmmb.a0000448","article-title":"Epigenetic drug interventions in breast cancer: A narrative review of current research and future directions","volume":"7","author":"Mungly","year":"2024","journal-title":"Progress In Microbes & Molecular Biology"},{"issue":"1","key":"10.1016\/bs.ircmb.2025.10.002_bib53","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13578-020-00415-1","article-title":"A three layered histone epigenetics in breast cancer metastasis","volume":"10","author":"Nandy","year":"2020","journal-title":"Cell & Bioscience"},{"issue":"1","key":"10.1016\/bs.ircmb.2025.10.002_bib54","doi-asserted-by":"crossref","DOI":"10.36877\/pmmb.a0000249","article-title":"Circular RNA-EPHB4 as a potential biotarget in colorectal cancer: A preliminary analysis","volume":"5","author":"Nasir","year":"2022","journal-title":"Progress In Microbes & Molecular Biology"},{"issue":"9","key":"10.1016\/bs.ircmb.2025.10.002_bib55","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrc.2016.72","article-title":"Hereditary breast and ovarian cancer: New genes in confined pathways","volume":"16","author":"Nielsen","year":"2016","journal-title":"Nature Reviews. Cancer"},{"issue":"26","key":"10.1016\/bs.ircmb.2025.10.002_bib56","doi-asserted-by":"crossref","first-page":"21783","DOI":"10.1074\/jbc.M112.355495","article-title":"DNA damage induces NF-\u03baB-dependent MicroRNA-21 up-regulation and promotes breast cancer cell invasion\u204e","volume":"287","author":"Niu","year":"2012","journal-title":"Journal of Biological Chemistry"},{"issue":"10","key":"10.1016\/bs.ircmb.2025.10.002_bib57","first-page":"2552","article-title":"Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells","volume":"54","author":"Ottaviano","year":"1994","journal-title":"Cancer Research"},{"issue":"2","key":"10.1016\/bs.ircmb.2025.10.002_bib58","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s12276-020-0382-4","article-title":"A short guide to histone deacetylases including recent progress on class II enzymes","volume":"52","author":"Park","year":"2020","journal-title":"Experimental & Molecular Medicine"},{"issue":"1","key":"10.1016\/bs.ircmb.2025.10.002_bib59","doi-asserted-by":"crossref","first-page":"75","DOI":"10.31557\/apjcb.2023.8.1.75-89","article-title":"Epigenetics and cancer: A comprehensive review","volume":"8","author":"Pathak","year":"2023","journal-title":"Asian Pacific Journal of Cancer Biology"},{"issue":"2","key":"10.1016\/bs.ircmb.2025.10.002_bib60","doi-asserted-by":"crossref","DOI":"10.1530\/JME-22-0110","article-title":"m6A Readers, writers, erasers, and the m6A epitranscriptome in breast cancer","volume":"70","author":"Petri","year":"2023","journal-title":"Journal of Molecular Endocrinology"},{"issue":"1","key":"10.1016\/bs.ircmb.2025.10.002_bib61","doi-asserted-by":"crossref","first-page":"26","DOI":"10.46223\/HCMCOUJS.tech.vi.13.1.799.2018","article-title":"Meta-analysis: Association between promoter hypermethylation of glutathione S-Transferase P1 (GSTP1) and breastcancer","volume":"13","author":"Ph\u01b0\u01a1ng","year":"2018","journal-title":"T\u1ea1p ch\u00ed Khoa h\u1ecdc \u0110\u1ea1i h\u1ecdc M\u01a1\u0309 Th\u00e0nh ph\u00f4\u0301 H\u00f4\u0300 Ch\u00ed Minh-K\u1ef9 thu\u00e2\u0323t v\u00e0 C\u00f4ng ngh\u00ea\u0323"},{"issue":"12","key":"10.1016\/bs.ircmb.2025.10.002_bib62","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1007\/s43032-024-01666-w","article-title":"BRCA1\/2 mutations and breast\/ovarian cancer risk: A new insights review","volume":"31","author":"Pourmasoumi","year":"2024","journal-title":"Reproductive Sciences"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155174","article-title":"Beyond genetics: Exploring the role of epigenetic alterations in breast cancer","volume":"254","author":"Prabhu","year":"2024","journal-title":"Pathology - Research and Practice"},{"issue":"17","key":"10.1016\/bs.ircmb.2025.10.002_bib64","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1158\/0008-5472.CAN-11-1896","article-title":"Estrogen-dependent gene transcription in human breast cancer cells relies upon proteasome-dependent monoubiquitination of histone H2B","volume":"71","author":"Prenzel","year":"2011","journal-title":"Cancer Research"},{"issue":"23","key":"10.1016\/bs.ircmb.2025.10.002_bib65","doi-asserted-by":"crossref","first-page":"10591","DOI":"10.1128\/MCB.25.23.10591-10603.2005","article-title":"Impaired retinoic acid (RA) signal leads to RAR\u03b22 epigenetic silencing and RA resistance","volume":"25","author":"Ren","year":"2005","journal-title":"Molecular and Cellular Biology"},{"issue":"1","key":"10.1016\/bs.ircmb.2025.10.002_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4048\/jbc.2019.22.e6","article-title":"BRCA1 and breast cancer: A review of the underlying mechanisms resulting in the tissue-specific tumorigenesis in mutation carriers","volume":"22","author":"Semmler","year":"2019","journal-title":"Journal of breast cancer"},{"issue":"4","key":"10.1016\/bs.ircmb.2025.10.002_bib67","doi-asserted-by":"crossref","first-page":"a018713","DOI":"10.1101\/cshperspect.a018713","article-title":"Erasers of histone acetylation: The histone deacetylase enzymes","volume":"6","author":"Seto","year":"2014","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"issue":"7","key":"10.1016\/bs.ircmb.2025.10.002_bib68","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/annonc\/mdv022","article-title":"Genetics of breast cancer: A topic in evolution","volume":"26","author":"Shiovitz","year":"2015","journal-title":"Annals of Oncology"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib69","first-page":"307","article-title":"Epigenetic regulation as a new target for breast cancer therapy","author":"Stearns","year":"2007","journal-title":"Breast Cancer (Tokyo, Japan)"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib70","unstructured":"Su, Y.A.-O., et al., Epigenetic reprogramming of epithelial mesenchymal transition in triple negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors. (1756\u20139966 (Electronic))."},{"issue":"8","key":"10.1016\/bs.ircmb.2025.10.002_bib71","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.3390\/ijms24087235","article-title":"Harnessing epigenetics for breast cancer therapy: The role of DNA methylation, histone modifications, and MicroRNA","volume":"24","author":"Szczepanek","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/bs.ircmb.2025.10.002_bib72","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/cmrp.cmrp_100_23","article-title":"The genetic basis of breast cancer: A comprehensive overview","volume":"13","author":"Talwar","year":"2023","journal-title":"Current Medicine Research and Practice"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.971288","article-title":"Epigenetics and environment in breast cancer: New paradigms for anti-cancer therapies","volume":"12","author":"Thakur","year":"2022","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.885635","article-title":"Molecular basis of epigenetic regulation in cancer diagnosis and treatment","volume":"13","author":"Tulsyan","year":"2022","journal-title":"Frontiers in Genetics"},{"issue":"3","key":"10.1016\/bs.ircmb.2025.10.002_bib75","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5306\/wjco.v9.i3.42","article-title":"Epitranscriptomics of cancer","volume":"9","author":"Tusup","year":"2018","journal-title":"World Journal of Clinical Oncology"},{"issue":"10","key":"10.1016\/bs.ircmb.2025.10.002_bib76","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1038\/bjc.2013.136","article-title":"Assessment of DNA methylation status in early stages of breast cancer development","volume":"108","author":"Van Hoesel","year":"2013","journal-title":"British Journal of Cancer"},{"issue":"5","key":"10.1016\/bs.ircmb.2025.10.002_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ijo.2021.5278","article-title":"DNA methylation and breast cancer: A way forward","volume":"59","author":"Vietri","year":"2021","journal-title":"International Journal of Oncology"},{"issue":"5","key":"10.1016\/bs.ircmb.2025.10.002_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.gendis.2023.04.040","article-title":"Epigenetics: Mechanisms, potential roles, and therapeutic strategies in cancer progression","volume":"11","author":"Wang","year":"2024","journal-title":"Genes & Diseases"},{"issue":"1","key":"10.1016\/bs.ircmb.2025.10.002_bib79","first-page":"6468773","article-title":"[Retracted] An overview of DNA methylation indicators for the course of oral precancer","volume":"2022","author":"Wang","year":"2022","journal-title":"Applied Bionics and Biomechanics"},{"issue":"1","key":"10.1016\/bs.ircmb.2025.10.002_bib80","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13148-016-0225-2","article-title":"Histone acetyltransferases: Challenges in targeting bi-substrate enzymes","volume":"8","author":"Wapenaar","year":"2016","journal-title":"Clinical Epigenetics"},{"issue":"7","key":"10.1016\/bs.ircmb.2025.10.002_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002656","article-title":"Epigenotyping in peripheral blood cell DNA and breast cancer risk: A proof of principle study","volume":"3","author":"Widschwendter","year":"2008","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/bs.ircmb.2025.10.002_bib82","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1186\/s12885-024-12950-y","article-title":"EZH2 mutation is associated with the development of visceral metastasis by enhancing proliferation and invasion and inhibiting apoptosis in breast cancer cells","volume":"24","author":"Wu","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib83","unstructured":"Xu, J., et al.\u00a0(no date). Roles of miRNA and lncRNA in triple-negative breast cancer. (1862\u20131783 (Electronic))."},{"key":"10.1016\/bs.ircmb.2025.10.002_bib84","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.engstruct.2017.09.007","article-title":"Experimental investigation of seismic behavior of ultra-high performance steel fiber reinforced concrete columns","volume":"152","author":"Xu","year":"2017","journal-title":"Engineering Structures"},{"issue":"1","key":"10.1016\/bs.ircmb.2025.10.002_bib85","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41597-023-02253-5","article-title":"Global trends and forecasts of breast cancer incidence and deaths","volume":"10","author":"Xu","year":"2023","journal-title":"Scientific Data"},{"issue":"4","key":"10.1016\/bs.ircmb.2025.10.002_bib86","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/EBC20200032","article-title":"Non-coding RNA in cancer","volume":"65","author":"Yan","year":"2021","journal-title":"Essays in Biochemistry"},{"issue":"7","key":"10.1016\/bs.ircmb.2025.10.002_bib87","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/cas.12166","article-title":"Cancer\u2010associated upregulation of histone H3 lysine 9 trimethylation promotes cell motility in vitro and drives tumor formation in vivo","volume":"104","author":"Yokoyama","year":"2013","journal-title":"Cancer Science"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib88","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00432-011-0998-9","article-title":"Elevated expression of USP22 in correction with poor prognosis in patients with invasive breast cancer","volume":"137","author":"Zhang","year":"2011","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"10.1016\/bs.ircmb.2025.10.002_bib89","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.3389\/fgene.2020.603552","article-title":"Perspectives on the role of histone modification in breast cancer progression and the advanced technological tools to study epigenetic determinants of metastasis","volume":"11","author":"Zhuang","year":"2020","journal-title":"Frontiers in Genetics"}],"container-title":["International Review of Cell and Molecular Biology","Epigenetic Regulation of Cancer - Part E"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1937644825001248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1937644825001248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T08:28:28Z","timestamp":1774600108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1937644825001248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443414237"],"references-count":89,"URL":"https:\/\/doi.org\/10.1016\/bs.ircmb.2025.10.002","relation":{},"ISSN":["1937-6448"],"issn-type":[{"value":"1937-6448","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}